These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 29051216)

  • 1. Prolyl 4-Hydroxylase Domain Protein 3 Overexpression Improved Obstructive Sleep Apnea-Induced Cardiac Perivascular Fibrosis Partially by Suppressing Endothelial-to-Mesenchymal Transition.
    Zhang GH; Yu FC; Li Y; Wei Q; Song SS; Zhou FP; Tong JY
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29051216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolyl 4-Hydroxylase Domain Protein 3-Inhibited Smooth-Muscle-Cell Dedifferentiation Improves Cardiac Perivascular Fibrosis Induced by Obstructive Sleep Apnea.
    Tong J; Yu FC; Li Y; Wei Q; Li C; Zhen P; Zhang G
    Biomed Res Int; 2019; 2019():9174218. PubMed ID: 31346526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel role of kallikrein-related peptidase 8 in the pathogenesis of diabetic cardiac fibrosis.
    Du JK; Yu Q; Liu YJ; Du SF; Huang LY; Xu DH; Ni X; Zhu XY
    Theranostics; 2021; 11(9):4207-4231. PubMed ID: 33754057
    [No Abstract]   [Full Text] [Related]  

  • 4. Relaxin inhibits cardiac fibrosis and endothelial-mesenchymal transition via the Notch pathway.
    Zhou X; Chen X; Cai JJ; Chen LZ; Gong YS; Wang LX; Gao Z; Zhang HQ; Huang WJ; Zhou H
    Drug Des Devel Ther; 2015; 9():4599-611. PubMed ID: 26316699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted gene deletion of prolyl hydroxylase domain protein 3 triggers angiogenesis and preserves cardiac function by stabilizing hypoxia inducible factor 1 alpha following myocardial infarction.
    Oriowo B; Thirunavukkarasu M; Selvaraju V; Adluri RS; Zhan L; Takeda K; Fong GH; Sanchez JA; Maulik N
    Curr Pharm Des; 2014; 20(9):1305-10. PubMed ID: 23978105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of prolyl hydroxylase 3 ameliorates cardiac dysfunction in diabetic cardiomyopathy.
    Xia Y; Gong L; Liu H; Luo B; Li B; Li R; Li B; Lv M; Pan J; An F
    Mol Cell Endocrinol; 2015 Mar; 403():21-9. PubMed ID: 25595486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Foxm1 is a critical driver of TGF-β-induced EndMT in endothelial cells through Smad2/3 and binds to the Snail promoter.
    Song S; Zhang R; Cao W; Fang G; Yu Y; Wan Y; Wang C; Li Y; Wang Q
    J Cell Physiol; 2019 Jun; 234(6):9052-9064. PubMed ID: 30378114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trimetazidine Reduces Cardiac Fibrosis in Rats by Inhibiting NOX2-Mediated Endothelial-to-Mesenchymal Transition.
    Chen X; Xia X; Dong T; Lin Z; Du L; Zhou H
    Drug Des Devel Ther; 2022; 16():2517-2527. PubMed ID: 35946039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-β1-induced SMAD2/3/4 activation promotes RELM-β transcription to modulate the endothelium-mesenchymal transition in human endothelial cells.
    Jiang Y; Zhou X; Hu R; Dai A
    Int J Biochem Cell Biol; 2018 Dec; 105():52-60. PubMed ID: 30120989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MFGE8 is down-regulated in cardiac fibrosis and attenuates endothelial-mesenchymal transition through Smad2/3-Snail signalling pathway.
    Wang B; Ge Z; Wu Y; Zha Y; Zhang X; Yan Y; Xie Y
    J Cell Mol Med; 2020 Nov; 24(21):12799-12812. PubMed ID: 32945126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amphiregulin promotes cardiac fibrosis post myocardial infarction by inducing the endothelial-mesenchymal transition via the EGFR pathway in endothelial cells.
    Liu L; Song S; Zhang YP; Wang D; Zhou Z; Chen Y; Jin X; Hu CF; Shen CX
    Exp Cell Res; 2020 May; 390(2):111950. PubMed ID: 32188578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infarct size-limiting effect of epoxyeicosatrienoic acid analog EET-B is mediated by hypoxia-inducible factor-1α via downregulation of prolyl hydroxylase 3.
    Neckář J; Hsu A; Hye Khan MA; Gross GJ; Nithipatikom K; Cyprová M; Benák D; Hlaváčková M; Sotáková-Kašparová D; Falck JR; Sedmera D; Kolář F; Imig JD
    Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1148-H1158. PubMed ID: 30074840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of myocyte-specific enhancer factor 2A improved diabetic cardiac fibrosis partially by regulating endothelial-to-mesenchymal transition.
    Chen XY; Lv RJ; Zhang W; Yan YG; Li P; Dong WQ; Liu X; Liang ES; Tian HL; Lu QH; Zhang MX
    Oncotarget; 2016 May; 7(21):31053-66. PubMed ID: 27105518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial HIF-2α contributes to severe pulmonary hypertension due to endothelial-to-mesenchymal transition.
    Tang H; Babicheva A; McDermott KM; Gu Y; Ayon RJ; Song S; Wang Z; Gupta A; Zhou T; Sun X; Dash S; Wang Z; Balistrieri A; Zheng Q; Cordery AG; Desai AA; Rischard F; Khalpey Z; Wang J; Black SM; Garcia JGN; Makino A; Yuan JX
    Am J Physiol Lung Cell Mol Physiol; 2018 Feb; 314(2):L256-L275. PubMed ID: 29074488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tongxinluo Attenuates Myocardiac Fibrosis after Acute Myocardial Infarction in Rats via Inhibition of Endothelial-to-Mesenchymal Transition.
    Yin Y; Zhang Q; Zhao Q; Ding G; Wei C; Chang L; Li H; Bei H; Wang H; Liang J; Jia Z
    Biomed Res Int; 2019; 2019():6595437. PubMed ID: 31317035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of prolyl hydroxylase domain-containing enzyme 3 (phd3) in zebrafish facilitates hypoxia tolerance.
    Liao Q; Deng H; Wang Z; Yu G; Zhu C; Jia S; Liu W; Bai Y; Sun X; Chen X; Xiao W; Liu X
    J Biol Chem; 2023 Dec; 299(12):105420. PubMed ID: 37923141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of BRD4 attenuates transverse aortic constriction- and TGF-β-induced endothelial-mesenchymal transition and cardiac fibrosis.
    Song S; Liu L; Yu Y; Zhang R; Li Y; Cao W; Xiao Y; Fang G; Li Z; Wang X; Wang Q; Zhao X; Chen L; Wang Y; Wang Q
    J Mol Cell Cardiol; 2019 Feb; 127():83-96. PubMed ID: 30529267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolyl hydroxylase 3 stabilizes the p53 tumor suppressor by inhibiting the p53-MDM2 interaction in a hydroxylase-independent manner.
    Xu Y; Gao Q; Xue Y; Li X; Xu L; Li C; Qin Y; Fang J
    J Biol Chem; 2019 Jun; 294(25):9949-9958. PubMed ID: 31092600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of prolyl hydroxylase domain proteins (PHD1, PHD3) stabilizes hypoxia inducible factor-1 alpha, promotes neovascularization, and improves perfusion in a murine model of hind-limb ischemia.
    Rishi MT; Selvaraju V; Thirunavukkarasu M; Shaikh IA; Takeda K; Fong GH; Palesty JA; Sanchez JA; Maulik N
    Microvasc Res; 2015 Jan; 97():181-8. PubMed ID: 25446011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia-inducible factor prolyl-hydroxylase-2 mediates transforming growth factor beta 1-induced epithelial-mesenchymal transition in renal tubular cells.
    Han WQ; Zhu Q; Hu J; Li PL; Zhang F; Li N
    Biochim Biophys Acta; 2013 Jun; 1833(6):1454-62. PubMed ID: 23466866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.